Centene (1CNC) Stock Forecast & Price Target

2 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

1CNC Analyst Ratings

Moderate Buy

6 Buy

9 Hold

0 Sell

Based on 15 analysts giving stock ratings to

Centene

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

1CNC Stock 12 Month Forecast

Average Price Target

€62.88

▲(12.37% Upside)

Based on 15 Wall Street analysts offering 12 month price targets for Centene in the last 3 months. The average price target is €62.88 with a high forecast of €69.39 and a low forecast of €56.38. The average price target represents a 12.37% change from the last price of €55.96.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"21":"€21","70":"€70","33.25":"€33.3","45.5":"€45.5","57.75":"€57.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":69.387164,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€69.39</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":62.882117375,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€62.88</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":56.377070749999994,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€56.38</span>\n  </div></div>","useHTML":true}}],"tickPositions":[21,33.25,45.5,57.75,70],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,54.68,55.811320307692306,56.94264061538461,58.073960923076925,59.20528123076923,60.33660153846154,61.46792184615384,62.59924215384615,63.73056246153846,64.86188276923076,65.99320307692308,67.12452338461539,68.25584369230769,{"y":69.387164,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,54.68,55.31093210576923,55.94186421153846,56.57279631730769,57.203728423076925,57.83466052884615,58.46559263461538,59.096524740384616,59.72745684615384,60.358388951923075,60.98932105769231,61.62025316346154,62.25118526923077,{"y":62.882117375,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,54.68,54.81054390384615,54.941087807692305,55.07163171153846,55.20217561538461,55.332719519230764,55.46326342307692,55.59380732692308,55.72435123076923,55.85489513461538,55.985439038461536,56.11598294230769,56.24652684615384,{"y":56.377070749999994,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":22.385,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.595,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.43,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":30.145,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32.89,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.265,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.295,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":37.82,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":29.025,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.3,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.84,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.12,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.68,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€69.39

Average Price Target€62.88

Lowest Price Target€56.38

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

John Stansel

J.P. Morgan

€52.04→€58.11

Hold

3.85%

Upside

Reiterated

08/04/26

J.P. Morgan Sticks to Their Hold Rating for Centene (CNC)

Lance Wilkes

Bernstein

€58.98→€68.52

Buy

22.44%

Upside

Reiterated

08/03/26

Centene price target raised to $79 from $68 at BernsteinCentene price target raised to $79 from $68 at Bernstein

Ryan Langston

TD Cowen

€56.38

Hold

0.75%

Upside

Assigned

07/30/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Centene (NYSE: CNC) and Dyne Therapeutics (NASDAQ: DYN)

Erin Wright

Morgan Stanley

€49.44→€57.24

Hold

2.30%

Upside

Reiterated

07/29/26

Erin Wright Raises Centene Price Target to $66 on Strong Execution but Maintains Hold Amid Sustainability Concerns

David S Macdonald

Truist Financial

€67.65→€69.39

Buy

23.99%

Upside

Reiterated

07/29/26

Truist Financial Keeps Their Buy Rating on Centene (CNC)

A.J. Rice

UBS

€52.91→€60.71

Hold

8.49%

Upside

Reiterated

07/29/26

Centene price target raised to $70 from $61 at UBSCentene price target raised to $70 from $61 at UBS

Michael Ha

Robert W. Baird

€39.9→€57.24

Hold

2.30%

Upside

Reiterated

07/29/26

Centene price target raised to $66 from $46 at Baird Centene price target raised to $66 from $46 at Baird

Andrew Mok CFA

Barclays

€65.05→€69.39

Buy

23.99%

Upside

Reiterated

07/29/26

Analysts Offer Insights on Healthcare Companies: Kuros Biosciences (Other OTC: CSBTF), Centene (NYSE: CNC) and Incyte (NASDAQ: INCY)

Ben Hendrix

RBC Capital

€61.58

Hold

10.04%

Upside

Reiterated

07/28/26

RBC Capital Reaffirms Their Hold Rating on Centene (CNC)

Sarah James

Cantor Fitzgerald

€65.05

Buy

16.24%

Upside

Reiterated

07/28/26

Analysts Are Bullish on These Healthcare Stocks: Centene (CNC), Ansell (ANSLF)

Jason Cassorla

Guggenheim

―

Hold

―

Reiterated

07/28/26

Guggenheim Sticks to Its Hold Rating for Centene (CNC)

Kevin Fischbeck

Bank of America Securities

€67.65

Buy

20.89%

Upside

Reiterated

07/28/26

Analysts Offer Insights on Healthcare Companies: Centene (NYSE: CNC), Incyte (NASDAQ: INCY) and IQVIA Holdings (NYSE: IQV)

Ann Hynes

Mizuho Securities

€54.64→€59.85

Hold

6.95%

Upside

Reiterated

07/13/26

Mizuho Securities Remains a Hold on Centene (CNC)

Stephen Baxter

Wells Fargo

€48.57→€59.85

Hold

6.95%

Upside

Reiterated

07/13/26

Centene price target raised to $69 from $56 at Wells FargoCentene price target raised to $69 from $56 at Wells Fargo

George Hill

Deutsche Bank

€69.39

Buy

23.99%

Upside

Upgraded

05/20/26

Centene upgraded to Buy from Hold at Deutsche BankCentene upgraded to Buy from Hold at Deutsche Bank

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

John Stansel

J.P. Morgan

€52.04→€58.11

Hold

3.85%

Upside

Reiterated

08/04/26

J.P. Morgan Sticks to Their Hold Rating for Centene (CNC)

Lance Wilkes

Bernstein

€58.98→€68.52

Buy

22.44%

Upside

Reiterated

08/03/26

Centene price target raised to $79 from $68 at BernsteinCentene price target raised to $79 from $68 at Bernstein

Ryan Langston

TD Cowen

€56.38

Hold

0.75%

Upside

Assigned

07/30/26

Analysts' Opinions Are Mixed on These Healthcare Stocks: Centene (NYSE: CNC) and Dyne Therapeutics (NASDAQ: DYN)

Erin Wright

Morgan Stanley

€49.44→€57.24

Hold

2.30%

Upside

Reiterated

07/29/26

Erin Wright Raises Centene Price Target to $66 on Strong Execution but Maintains Hold Amid Sustainability Concerns

David S Macdonald

Truist Financial

€67.65→€69.39

Buy

23.99%

Upside

Reiterated

07/29/26

Truist Financial Keeps Their Buy Rating on Centene (CNC)

A.J. Rice

UBS

€52.91→€60.71

Hold

8.49%

Upside

Reiterated

07/29/26

Centene price target raised to $70 from $61 at UBSCentene price target raised to $70 from $61 at UBS

Michael Ha

Robert W. Baird

€39.9→€57.24

Hold

2.30%

Upside

Reiterated

07/29/26

Centene price target raised to $66 from $46 at Baird Centene price target raised to $66 from $46 at Baird

Andrew Mok CFA

Barclays

€65.05→€69.39

Buy

23.99%

Upside

Reiterated

07/29/26

Analysts Offer Insights on Healthcare Companies: Kuros Biosciences (Other OTC: CSBTF), Centene (NYSE: CNC) and Incyte (NASDAQ: INCY)

Ben Hendrix

RBC Capital

€61.58

Hold

10.04%

Upside

Reiterated

07/28/26

RBC Capital Reaffirms Their Hold Rating on Centene (CNC)

Sarah James

Cantor Fitzgerald

€65.05

Buy

16.24%

Upside

Reiterated

07/28/26

Analysts Are Bullish on These Healthcare Stocks: Centene (CNC), Ansell (ANSLF)

Jason Cassorla

Guggenheim

―

Hold

―

Reiterated

07/28/26

Guggenheim Sticks to Its Hold Rating for Centene (CNC)

Kevin Fischbeck

Bank of America Securities

€67.65

Buy

20.89%

Upside

Reiterated

07/28/26

Analysts Offer Insights on Healthcare Companies: Centene (NYSE: CNC), Incyte (NASDAQ: INCY) and IQVIA Holdings (NYSE: IQV)

Ann Hynes

Mizuho Securities

€54.64→€59.85

Hold

6.95%

Upside

Reiterated

07/13/26

Mizuho Securities Remains a Hold on Centene (CNC)

Stephen Baxter

Wells Fargo

€48.57→€59.85

Hold

6.95%

Upside

Reiterated

07/13/26

Centene price target raised to $69 from $56 at Wells FargoCentene price target raised to $69 from $56 at Wells Fargo

George Hill

Deutsche Bank

€69.39

Buy

23.99%

Upside

Upgraded

05/20/26

Centene upgraded to Buy from Hold at Deutsche BankCentene upgraded to Buy from Hold at Deutsche Bank

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

AVBPArriVent BioPharma, Inc.

BTSGBrightSpring Health Services, Inc.

ZURAZura Bio

TNYATenaya Therapeutics

JBIOJade Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Centene

3 Months

Michael WiederhornOppenheimer

Success Rate

33/50 ratings generated profit

Average Return

+3.98%

Copying Michael Wiederhorn's trades and holding each position for 3 Months would result in 66.00% of your transactions generating a profit, with an average return of +3.98% per trade.

1 Year

Michael WiederhornOppenheimer

Success Rate

27/50 ratings generated profit

Average Return

+8.92%

Copying Michael Wiederhorn's trades and holding each position for 1 Year would result in 54.00% of your transactions generating a profit, with an average return of +8.92% per trade.

2 Years

Michael WiederhornOppenheimer

Success Rate

30/50 ratings generated profit

Average Return

+9.43%

Copying Michael Wiederhorn's trades and holding each position for 2 Years would result in 60.00% of your transactions generating a profit, with an average return of +9.43% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1CNC Analyst Recommendation Trends

Rating

Apr 26

May 26

Jun 26

Jul 26

Aug 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 1CNC has received 13 Buy Ratings, 16 Hold Ratings, and 0 Sell Ratings. 1CNC average Analyst price target in the past 3 months is 62.88.

Each month's total comprises the sum of three months' worth of ratings.

1CNC Financial Forecast

1CNC Earnings Forecast

Next quarter’s earnings estimate for 1CNC is €0.08 with a range of €0.00 to €0.29. The previous quarter’s EPS was €2.18. 1CNC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 44.90% of the time in the same period. In the last calendar year 1CNC has Performed in-line its overall industry.

1CNC Sales Forecast

Next quarter’s sales forecast for 1CNC is €40.92B with a range of €39.63B to €42.71B. The previous quarter’s sales results were €46.54B. 1CNC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 59.72% of the time in the same period. In the last calendar year 1CNC has Performed in-line its overall industry.

1CNC Stock Forecast FAQ

What is IT:1CNC’s average 12-month price target, according to analysts?

Based on analyst ratings, Centene’s 12-month average price target is 62.88.

What is IT:1CNC’s upside potential, based on the analysts’ average price target?

Centene has 12.37% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Centene a Buy, Sell or Hold?

Centene has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 9 hold ratings and 0 sell ratings.

What is Centene’s share price target?

The average share price target for Centene is 62.88. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €69.39 ,and the lowest forecast is €56.38. The average share price target represents 12.37% Increase from the current price of €55.96.

What do analysts say about Centene?

Centene’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 15 Wall Streets Analysts.

How can I buy shares of Centene?

To buy shares of IT:1CNC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Centene (1CNC) Stock Forecast & Price Target

1CNC Analyst Ratings

1CNC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Centene

1CNC Analyst Recommendation Trends

1CNC Financial Forecast

1CNC Earnings Forecast

1CNC Sales Forecast

1CNC Stock Forecast FAQ

Detailed List of Analyst Forecasts